CN Patent

CN102256942B — 1-(4-{1-[(e)-4-环己基-3-三氟甲基-苄氧基亚氨基]-乙基}-2-乙基-苄基)-氮杂环丁烷-3-甲酸的多晶型物

Assigned to Novartis AG · Expires 2013-07-24 · 13y expired

What this patent protects

本发明涉及1-(4-{1-[(E)-4-环己基-3-三氟甲基-苄氧基亚氨基]-乙基}-2-乙基-苄基)-氮杂环丁烷-3-甲酸(化合物I)的新晶形(A型)、含有所述晶形的药物组合物、形成所述晶形的方法和其在医疗中的用途。

USPTO Abstract

本发明涉及1-(4-{1-[(E)-4-环己基-3-三氟甲基-苄氧基亚氨基]-乙基}-2-乙基-苄基)-氮杂环丁烷-3-甲酸(化合物I)的新晶形(A型)、含有所述晶形的药物组合物、形成所述晶形的方法和其在医疗中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN102256942B
Jurisdiction
CN
Classification
—
Expires
2013-07-24
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.